Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 4.5 HKD 2.04% Market Closed
Market Cap: 20.4B HKD
Have any thoughts about
Shandong Weigao Group Medical Polymer Co Ltd?
Write Note

Gross Margin
Shandong Weigao Group Medical Polymer Co Ltd

49.9%
Current
53%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.9%
=
Gross Profit
6.5B
/
Revenue
13B

Gross Margin Across Competitors

Country CN
Market Cap 20.6B HKD
Gross Margin
50%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 38.6B CHF
Gross Margin
55%
Country DK
Market Cap 204.5B DKK
Gross Margin
68%
Country US
Market Cap 17.2B USD
Gross Margin
70%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country KR
Market Cap 9.8T KRW
Gross Margin
15%
Country CA
Market Cap 7B USD
Gross Margin
61%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Country UK
Market Cap 4.9B GBP
Gross Margin
56%
Country US
Market Cap 6B USD
Gross Margin
47%
No Stocks Found

Shandong Weigao Group Medical Polymer Co Ltd
Glance View

Market Cap
20.6B HKD
Industry
Health Care

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of medical devices. The company is headquartered in Weihai, Shandong. The company went IPO on 2004-02-27. The firm sells products under brand names of Jierui and Wego Ortho. The firm operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The firm is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

Intrinsic Value
8.99 HKD
Undervaluation 50%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.9%
=
Gross Profit
6.5B
/
Revenue
13B
What is the Gross Margin of Shandong Weigao Group Medical Polymer Co Ltd?

Based on Shandong Weigao Group Medical Polymer Co Ltd's most recent financial statements, the company has Gross Margin of 49.9%.